Selective Interleukin-23 P19 Inhibition: Another Game Changer in Psoriasis? Focus on Risankizumab

AuthID
P-00M-ZME
1
Author(s)
Tipo de Documento
Article
Year published
2017
Publicado
in DRUGS, ISSN: 0012-6667
Volume: 77, Número: 14, Páginas: 1493-1503 (11)
Indexing
Publication Identifiers
Wos: WOS:000409181500001
Source Identifiers
ISSN: 0012-6667
Export Publication Metadata
Info
At this moment we don't have any links to full text documens.